Influence Explorer

• Summary

  overview of the committee's finances

  Total Raised:

  $256,231

  Total Spent:

  $279,736

  Cash on Hand:

  $31,312

  Debts:

  $0

• Top Recipients

  Employee Color Block

  Individuals

  PAC Color Block

  PAC

  Includes contributions from the organization’s employees, their family members, and its political action committee.

• Republicans vs. Democrats

  in dollars. "Other" includes 3rd parties and organizations without official party affiliation.

• State vs. Federal

  in dollars

• Top PAC Recipients

  Employee Color Block

  Individuals

  PAC Color Block

  PAC

  Includes contributions from the organization’s employees, their family members, and its political action committee.

Lobbying On Behalf of Boston Scientific Corp

• Names of Lobbyists

  • Brenda Becker,
  • James Hawkins III,
  • James Hawkins III,
  • Courtney Johnson,
  • John Manthei,
  • Michael Mattoon,
  • Bob Brooks,
  • Michelle P Easton,
  • Isaac A Fordjour,
  • Isaac A Fordjour,

• Firm Hired	Amount
  Tarplin, Downs & Young	$180,000
  Alpine Group	$150,000
  Latham & Watkins	$30,000

• Most Frequently Disclosed Lobbying Issues

  • Health Issues,
  • Taxes,
  • Fed Budget & Appropriations,
  • Medicare & Medicaid,
  • Trade,
  • Copyright, Patent & Trademark,
  • Education,
  • Manufacturing,
  • Medical Research & Clin Labs,
  • Transportation

The tables show occurrences of "Boston Scientific Corp" in public comments on proposed federal regulations.

• Mentions in Document Text

  • Mentions
  • Agency
  • Docket
  • Date
  • Toggle 2 FDA Boston Scientific Corp. ION™ Paclitaxel-Eluting Coronary Stent System (Monorail and Over-the-Wire Systems)P100023; Approved 4/22/11 2011
  • Toggle 1 FDA Carl Zeiss Meditec, Inc., Premarket Approval for MEL 80™ Excimer Laser System, P060004/S001, Approved 3/28/11 2011
  • Toggle 1 FDA Premarket Approval for Abbott Molecular, Inc., Abbott RealTime HCV, Abbott RealTime HCV Amplification Reagent Kit, Abbott RealTime HCV Control Kit, Abbott RealTime HCV Calibrator Kit, and optional UNG Uracil-M-Glycosylase (UNG) P100017, Approved 5/17/11 2011
  • Toggle 1 FDA Premarket Approval for Roche Molecular Systems, Inc. cobas HPV Test, P100020 Approved 4/19/11 2011
  • Toggle 1 FDA Premarket Approval for Small Bone Innovations, Inc., Scandinavian Total Ankle Replacement System (STAR Ankle) P050050, Approved 5/27/2009 2011
  • Toggle 1 FDA cPAX Aneurysm Treatment System, H100002 2011
  • Toggle 1 FDA Premarket Approval for St. Jude Medical, St. Jude Medical Trifecta™ Valve, P100029 Approved 4/20/11 2011
  • Toggle 1 FDA Premarket Approval for Ortho-Clinical Diagnostics, Inc., VITROS® Immunodiagnostic Products HBeAg Reagent Pack, Calibrator and Controls P090028, Approved 5/11/11 2011
  • Toggle 1 FDA Cordis Corporation; Premarket Approval for EXOSEAL Vascular Closure Device, P100013; Approved 5/19/11 2011
  • Toggle 1 FDA Premarket Approval for Abbott Vascular RX Acculink Carotid Stent System P040012/S034 - Approved 5/6/11 2011

Note: Company names in federal spending data are not standardized. The table below is included only as a sample of what is available in the data and has not been reviewed for accuracy or completeness. To investigate the data further, use the links at the bottom of the table.